Smartleaf Asset Management’s MaxCyte MXCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-1,881
Closed -$2.93K 3608
2025
Q4
$2.93K Buy
1,881
+1,422
+310% +$2.27K ﹤0.01% 2870
2025
Q3
$688 Buy
459
+236
+106% +$410 ﹤0.01% 2809
2025
Q2
$490 Buy
+223
New +$540 ﹤0.01% 2589
2025
Q1
Sell
-470
Closed -$1.93K 2958
2024
Q4
$1.93K Buy
470
+298
+173% +$1.13K ﹤0.01% 2546
2024
Q3
$665 Buy
+172
New +$725 ﹤0.01% 2746

Other funds holding MXCT

Smartleaf Asset Management's MXCT Position: Q1 2026 in Review

Smartleaf Asset Management sold out of MaxCyte (MXCT) in Q1 2026, closing a stake of 1,881 shares — an estimated $2.93K sold.

Smartleaf Asset Management first reported a position in MXCT in Q3 2024 and held it in 5 quarters. The position peaked at $2.93K in Q4 2025. 130 funds tracked by Wall St. Rank hold MXCT as of Q1 2026.

  • Smartleaf Asset Management reported no remaining MaxCyte position as of Q1 2026 after selling out during the quarter.
  • Smartleaf Asset Management sold 1,881 MaxCyte shares in Q1 2026, an estimated $2.93K.
  • Smartleaf Asset Management first reported a position in MaxCyte in Q3 2024 and held it in 5 quarters.
  • Smartleaf Asset Management's MaxCyte position peaked at $2.93K in Q4 2025.
  • 130 funds tracked by Wall St. Rank held MaxCyte as of Q1 2026.

Based on Smartleaf Asset Management's 13F filing for Q1 2026, filed 15 May 2026.